Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
9,097
datasets available to search
ShareScore release 0.9.0
Dataset results
9,097 results for “wild”
Comparison of A140 and Erbitux Combined With mfolfox6 to Evaluate Efficacy and Safety of First-line Treatment for Ras Wild-type mCRC
ClinicalTrials.gov study NCT04835142. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of Triweekly Cetuximab in Combination With Capecitabine as First-line Maintenance Treatment for KRAS/BRAF Wild-type Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT05775900. IPD Sharing: Not stated. Countries: 1. Publications: 0.
BIBF1120 in Patients With Advanced FGFR3 Mutated,Overexpressed,or Wild Type Urothelial Carcinoma
ClinicalTrials.gov study NCT02278978. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Chemotherapy Combined Autologous Cytokine-induced Killer Cells in Naive Stage IV EGFR-wild Type Lung Adenocarcinoma
ClinicalTrials.gov study NCT02621333. IPD Sharing: NO. Countries: 1. Publications: 4.
Bortezomib and Pegylated Liposomal Doxorubicin in BRCA Wild-type Platinum-resistant Recurrent Ovarian Cancer Patients
ClinicalTrials.gov study NCT03509246. IPD Sharing: NO. Countries: 1. Publications: 5.
Single Agent Regorafenib in First-line for Metastatic/Unresectable KIT/PDGFR Wild Type GIST
ClinicalTrials.gov study NCT02638766. IPD Sharing: NO. Countries: 3. Publications: 1.
Avelumab Plus Cetuximab in Pre-treated RAS Wild Type Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT04561336. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Panitumumab Combination Study With Rilotumumab or Ganitumab in Wild-type Kirsten Rat Sarcoma Virus Oncogene Homolog (KRAS) Metastatic Colorectal Cancer (mCRC)
ClinicalTrials.gov study NCT00788957. IPD Sharing: Not stated. Countries: 0. Publications: 2.
Impacts of Wild Blueberries on Appetite and Weight Regulation
ClinicalTrials.gov study NCT05736432. IPD Sharing: NO. Countries: 1. Publications: 7.
Wild-Type Reovirus, Bortezomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT02514382. IPD Sharing: Not stated. Countries: 1. Publications: 1.
KRAS Wild-type Metastatic Colorectal Cancer Trial
ClinicalTrials.gov study NCT00879385. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of Neratinib +Trastuzumab or Neratinib + Cetuximab in Patients With KRAS/NRAS/BRAF/PIK3CA Wild-Type Metastatic Colorectal Cancer by HER2 Status
ClinicalTrials.gov study NCT03457896. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Efficacy Study of MEHD7945A + FOLFIRI Versus Cetuximab + FOLFIRI as Second Line Therapy in Participants With KRAS Wild-Type Metastatic Colorectal Cancer (mCRC)
ClinicalTrials.gov study NCT01652482. IPD Sharing: Not stated. Countries: 10. Publications: 1.
Role of Circulating Tumour DNA Testing in Assessing for Alterations of Primary Anti-EGFR Resistance in RAS/RAF Wild-type Metastatic Colorectal Cancer Patients
ClinicalTrials.gov study NCT05051592. IPD Sharing: NO. Countries: 1. Publications: 8.
Study of First-line Single-agent Panitumumab in Frail Elderly Patients With Advanced Wild Type K-RAS Colorectal Cancer
ClinicalTrials.gov study NCT01126112. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Intermittent or Continuous Panitumumab Plus FOLFIRI for RAS/B-RAF Wild-type Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT04425239. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Trial of Anlotinib Combined With Docetaxel in Patients With Wild-type Advanced Non-squamous Non Small Cell Lung Cancer
ClinicalTrials.gov study NCT04619537. IPD Sharing: NO. Countries: 1. Publications: 3.
Study of Panitumumab-Capecitabine-Oxaliplatin In Wild-Type K-Ras Metastatic Colorectal Cancer Patients
ClinicalTrials.gov study NCT01215539. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients
ClinicalTrials.gov study NCT04080843. IPD Sharing: NO. Countries: 1. Publications: 1.
The Molecular Mechanism of RAS Wild-type mCRC Resistance to Anti-EGFR-antibody
ClinicalTrials.gov study NCT04466267. IPD Sharing: Not stated. Countries: 1. Publications: 5.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.